Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005954 · ClinicalTrials.gov registry record · Phase 2
Temozolomide in Treating Patients With Brain Metastases
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00005954: Completed Phase 2 study, sponsored by Duke University.
NCT00005954 is a Phase 2 study that has completed, run by Duke University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005954, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have brain metastases.
Interventions
- DRUG temozolomide
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-08 |
| Est. Completion | 2003-06 |
| Phase | Phase 2 |
What the finished NCT00005954 record still lists
NCT00005954 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which temozolomide is the first listed.
NCT00005954 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005954 about?
NCT00005954 is a clinical study titled "Temozolomide in Treating Patients With Brain Metastases". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have brain metastases.
What is the current status of trial NCT00005954?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-08. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00005954?
The interventions under investigation include: temozolomide (DRUG).
Who is sponsoring clinical trial NCT00005954?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia